Iron Chelation and Nanoparticle Target Delivery in the Development of New Multifunctional disease-modifying Drugs for Alzheimer‘s Disease

Click to increase image sizeClick to decrease image size

Financial & competing interests disclosure

The authors thank the NIH (5R01NS52677 to Gang Liu), the NIH RCMI Center for Interdisciplinary Health Research (GI2-RR013646 to George Perry) and the Alzheimer‘s Association for their financial support. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or material discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.